Tag: TSX:APS

October 2, 2018

3 Top Biotech Stocks on the TSX Year-to-Date

Which biotech stocks on the TSX have performed the best year-to-date? These three companies have risen to the top of...
September 27, 2018

Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806

Aptose Biosciences (NASDAQ:APTO, TSX:APS), today announced that the European Patent Office has issued European Patent No. EP2940014B1 for CG-806, a...
June 29, 2018

FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers

Aptose Biosciences (NASDAQ:APTO) (TSX:APS) announced that the U.S. Food and Drug Administration (FDA) has notified the company that it has...
May 22, 2018

Aptose Provides Molecule Update and Q1 Financial Results

Aptose Bioscience is the only company with a small molecule in development without those toxicities for AML patients with its...